Delivery Order SPE2DR25D2206-SPE2DR26F9PN7

<p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 5, 2026, for Ibrance 75 mg tablets (7-count) with a ceiling value of $8,561.41 under firm fixed-price terms.</p> <p>Place of performance is Conshohocken, PA. The order is due for ultimate completion on February 27, 2026. No set-aside was used.</p>

<p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 5, 2026, for Ibrance 100 mg tablets (7-count), with a ceiling value of $8,559.84 under firm fixed pricing.</p> <p>Place of performance is Conshohocken, PA. The order is scheduled for ultimate completion by February 27, 2026. No set-aside was used.</p>

<p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 5, 2026, for IBRANCE 75 MG Tablet 7S with a ceiling value of $8,561.41.</p> <p>The order is issued under the DLA Troop Support Medical IDC (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at up to $999,999,999.00 through December 2026. Place of performance is Conshohocken, PA. Ultimate completion date is February 27, 2026. Pricing is firm fixed price with no set-aside applied.</p>

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 29, 2025, for the supply of Ibrance 100 mg capsules (21-count packages) with a ceiling value of $8,559.84. This firm fixed-price delivery order represents a non-competitive set-aside award and is scheduled for completion by January 21, 2026. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...

The Defense Logistics Agency awarded a delivery order valued at $8,123.96 to AmerisourceBergen Drug Corp for the supply of Ibrance 75 mg capsules (21-count package) on August 1, 2025, with an ultimate completion date of August 22, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, meaning it was competitively awarded. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this...

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Ibrance 100 mg capsules (21-count packages) with a ceiling value of $8,122.48. This firm fixed-price delivery order, which is expected to be completed by June 24, 2025, carries no set-aside designation and represents a competitively awarded contract. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...

The Defense Logistics Agency awarded a delivery order valued at $8,561.41 to AmerisourceBergen Drug Corp for the supply of Ibrance 75 mg capsules (21-count packages) on January 30, 2026, with an ultimate completion date of February 23, 2026. This firm fixed-price, non-set-aside contract is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery...

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Ibrance 75 mg tablets (7-count packages) with a ceiling value of $8,123.96. This is a firm fixed-price delivery order with no set-aside designation, issued as part of a competitive award process. The order is scheduled for ultimate completion by October 21, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 8, 2026, for the supply of Ibrance 75 mg capsules (21-count packaging) valued at $8,561.41, with an ultimate completion date of January 30, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the awardee's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp operates as a subsidiary of parent company Cencora, Inc.,...

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Ibrance 125 mg capsules (21-count packaging) with a contract value of $8,118.08. This is a firm fixed price delivery order with no set-aside designation, issued under a competitive procurement process. The order is expected to be completed by September 30, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....